KRAS and pancreatic neoplasm: In contrast, when tested on tumorspheres isolated from the KRAS wild type pancreatic cancer cell line BxPC-3, no significant effect of JVG45 was observed (two-sample t-test, t (4)  =  1.224; p = 0.2880; Fig. 5d).